Teprotumumab for patients with active thyroid eye disease: a pooled data analysis, subgroup analyses, and off-treatment follow-up results from two randomised, double-masked, placebo-controlled, multicentre trials

Publication date: Available online 15 April 2021Source: The Lancet Diabetes & EndocrinologyAuthor(s): George J Kahaly, Raymond S Douglas, Robert J Holt, Saba Sile, Terry J Smith
Source: The Lancet Diabetes and Endocrinology - Category: Endocrinology Source Type: research